ABC News
As posted by @ABC on X
Compared on: the record on NAION incidence rates among GLP-1 users and comparator groups reported by the FDA..
THE CLAIM · NOV 15, 2026
“The FDA found 6.4 cases per 100,000 person-years among GLP-1 users, compared with 3.8 among those receiving a placebo or another diabetes medication”
ABC News, as posted by @ABC · Read the post
THE RECORD
“showed an occurrence of 6.4 NAION cases per 100,000 person-years (PY) in patients treated with GLP-1 RAs compared to 3.8 NAION cases per 100,000 PY for patients treated with a placebo or a non-GLP-1 RA glucose-lowering medication.”
FDA Requires Safety Labeling Changes for GLP-1 RAs · Read
OPEN